An American gene sequencing company is working towards a universal blood test to identify early-stage cancers in people with no symptoms of the disease. San Diego-based Illumina Inc. is forming a new company, called Grail, with more than AED 350 million of finance. Microsoft’s Bill Gates and Jeff Bezos, founder of Amazon.com are two of the high profile investors.

US says oil from strategic reserve to start reaching market next week
Standard Chartered issues clarification on local operations
Cyprus aims for gas exports by 2028 as conflict heightens supply tensions
DP World reports record $24.4bn revenue for 2025
